Structure Unresectable/neoadjuvant recommendationsa Adjuvant/resected recommendationsb Kidney (right and left) Not more than 30 % of the total volume can receive ≥18 Gy. If only one kidney is functional, not more…
Fig. 12.1 Representative contours for postoperative external beam radiotherapy of a pT2N1M0 stage IIIB adenocarcinoma of the gallbladder. Representative axial (a) and coronal (b) sections of the tumor bed ITV…
Fig. 18.1 Patient with oligometastatic pancreatic cancer with an enlarging right hepatic lobe segment 6 lesion measuring 1.8 cm, treated with stereotactic body radiation, 54 Gy in three fractions. Axial…
Study Inclusion Number of patients Type of metastasis Total dose per fraction Toxicity Median follow-up (months) Local control rate Survival Herfarth et al. (2001) [38] 1–3 lesions 37 Not reported…
T1 ≤ 2 cm N1 Perirectal node(s) M0 No distant metastasis T2 2–5 cm N2 Unilateral internal iliac and/or inguinal node(s) M1 Distant metastasis T3 > 5 cm N3 Perirectal…
(1) Harvard Radiation Oncology Program, Boston, MA, USA (2) Brigham and Women’s Hospital and Dana-Farber Cancer Institute, Boston, MA, USA (3) Massachusetts General Hospital, Boston, MA, USA Sophia C. Kamran…
Isolated locoregional failure rate (%) Initial distant failure rate (%) Extrahepatic/hilar cholangiocarcinoma Surgery alone 4–34 24–40 +adjuvant chemoradiotherapy (SWOG 0809) 8 29 Gallbladder cancer Surgery alonea 3–33 15–51 +adjuvant…
1 point 2 points 3 points Total bilirubin (mg/dl)a <3.4 3.4–5.0 >5.0 INR <1.7 1.7–2.3 >2.3 Albumin (g/dl) >3.5 2.8–3.5 <2.8 Ascites None Mild Moderate–severe Hepatic encephalopathy None Medically…
© Springer International Publishing AG 2017Theodore Hong and Prajnan Das (eds.)Radiation Therapy for Gastrointestinal Cancers10.1007/978-3-319-43115-4_5 5. Gastric Cancer: Background and Clinical Evidence Christopher L. Hallemeier1 and Michael G. Haddock1 (1) Mayo Clinic, Rochester, MN 55905, USA Michael G. Haddock Email:…
Fig. 3.1 American Joint Committee on Cancer 2010 esophageal cancer staging system 3.5 Prognostic Factors (a) According to SEER Data, the 5-year survival of patients with esophageal cancer…
